Oxidized LDL and Risk of Coronary Heart Disease

Oxidized LDL and Risk of Coronary Heart Disease

Oxidized LDL cholesterol (ox-LDL) is considered to be a key factor of initiating and accelerating coronary heart disease CHD and diabetes Mellitus DM , is associated with several mechanisms one of them Oxidative stress. The aim of this study was to find the association between ox- LDL ,HDL-C , TG ,...

Full description

Saved in:

Bibliographic Details
Main Author:	Luma Abdalmunim Baker
Format:	Article
Language:	English
Published:	Tikrit University 2023-01-01
Series:	Tikrit Journal of Pure Science
Subjects:	Oxidized LDL Atherosclerosis Diabetes Mellitus Coronary heart disease
Online Access:	https://tjpsj.org/index.php/tjps/article/view/631
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Oxidized LDL and lipids as risk factors for ischemic heart disease in type 2 diabetes
by: Zamaklar Miroslava N., et al.
Published: (2005-01-01)

Phenolic compounds naturally present in olive oil and lowering of blood LDL‐cholesterol and systolic blood pressure, therefore reducing the risk of coronary heart disease: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA), et al.
Published: (2025-05-01)

Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year‡
by: Núria Puig, et al.
Published: (2025-02-01)

Cardiovascular Outcomes of Early LDL-C Goal Achievement in Patients with Very-High-Risk ASCVD
by: Ah-Ram Kim, et al.
Published: (2025-02-01)

Different Associations between Lipid Levels and Risk for Heart Failure according to Diabetes Progression
by: Seung-Hwan Lee, et al.
Published: (2025-01-01)

Interventional cardiology and diabetes mellitus: age of effective coronary heart disease treatment
by: Victor Yur'evich Kalashnikov, et al.
Published: (2011-03-01)

Low LDL particle levels associate with coronary arteries free from atherosclerosis in long-term type 1 diabetes: the Dialong study
by: Marte Narum, et al.
Published: (2025-07-01)

Interrelation of individual risk and coronary atherosclerosis in coronary heart disease prognosis
by: E. V. Kotelnikova, et al.
Published: (2004-02-01)

The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis
by: Jie Dong, et al.
Published: (2025-06-01)

LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND VARYING DEGREE OF CORONARY STENOSIS
by: I. N. Ozerova, et al.
Published: (2013-08-01)

A study on high ApoB and LDL levels in people attending a tertiary hospital in Coimbatore, India
by: Hariharan V, et al.
Published: (2024-04-01)

Characteristics of patients with coronary artery disease and type 2 diabetes mellitus undergoing elective percutaneous coronary intervention
by: Anastasiya G. Neeshpapa, et al.
Published: (2025-01-01)

Association of sdLDL-C/LDL-C ratio with atherosclerotic cardiovascular disease: a case-control study
by: Yuxin Yang, et al.
Published: (2025-06-01)

PATHOGENETIC FACTORS OF CORONARY HEART DISEASE AND HELICOBACTER PYLORI INFECTION
by: O. N. Pavlov
Published: (2012-04-01)

Karotid Endarterektomi geçiren hastalarda kontrolsüz diyabetin statin kullanan ve kullanmayan hastalarda LDL seviyelerine etkisi
by: Ateş Duman, et al.
Published: (2016-06-01)

Asymmetric dimethylarginine and NO metabolites in patients with acute and chronic coronary heart disease
by: A. S. Galyavich, et al.
Published: (2009-02-01)

Synergistic effects of serum albumin and HDL cholesterol concentrations on serum oxidized LDL cholesterol concentration in obese individuals with normal glycoregulation and patients with type 2 diabetes mellitus
by: Pejin Radoslav, et al.
Published: (2025-01-01)

Which Parameter Related to Low-Density Lipoprotein Cholesterol is Superior for Predicting the Recurrence of Myocardial Infarction in Young Patients with Previous Coronary Heart Disease? A Real-World Study
by: Feng Xu, et al.
Published: (2025-02-01)

RISK FACTORS OF MAJOR CARDIOVASCULAR EVENTS IN LONG-TERM PERIOD OF CORONARY BYPASS IN PATIENTS WITH ISCHEMIC HEART DISEASE AND 2ND TYPE DIABETES MELLITUS
by: A. N. Sumin, et al.
Published: (2015-06-01)

OxLDL plasma levels in patients with Alzheimer's disease
by: Marina Felipe Grossi, et al.

Possible mechanisms of hypercholesterolemia and clinico-prognostic effects of lipid-lowering therapy in patients with coronary heart disease. (Literature review and original data analysis)
by: A. P. Vasilyev, et al.
Published: (2004-12-01)

ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS
by: M. M. Petina, et al.
Published: (2011-04-01)

LDL cholesterol burden in elderly patients with familial hypercholesterolemia: Insights from real-world data
by: Torunn Melnes, et al.
Published: (2025-06-01)

CHLAMYDIA PNEUMONIAE AS A FACTOR OF CORONARY HEART DISEASE DESTABILIZATION
by: Z. G. Gadjiyeva, et al.
Published: (2003-08-01)

LUNG DIFFUSION CAPACITY AND NON-SPECIFIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS
by: E. D. Bazdyrev, et al.
Published: (2013-12-01)

Carvedilol effectiveness in complex treatment of patients with arterial hypertension, coronary heart disease, and Type 2 diabetes mellitus
by: R. M. Shakirova, et al.
Published: (2007-10-01)

Lipoprotein(a) and cardiovascular disease: Evidence, recommendations and emerging therapies
by: Wong Nathan D.
Published: (2025-01-01)

Dyslipidemia is Associated with Coronary Heart Disease in Patients with Type 2 Diabetes Mellitus at a Tertiary Hospital in Surabaya, Indonesia
by: Rizqi Nabila Ramadhani, et al.
Published: (2025-01-01)

Atherogenic circulating lipoproteins in ischemic stroke
by: Sonia Benitez, et al.
Published: (2024-12-01)

Predictive value of system immune-inflammation index for the severity of coronary stenosis in patients with coronary heart disease and diabetes mellitus
by: Haiming Wang, et al.
Published: (2024-12-01)

RISK FACTOR CONTROL IN PATIENTS WITH CORONARY HEART DISEASE – RESIDENTS OF A NORTH CAUCASUS REGION
by: R. T. Didigova, et al.
Published: (2011-08-01)

Local myocardial contractility disturbances in patients with coronary heart disease and Type 2 diabetes mellitus
by: Z. O. Georgadze, et al.
Published: (1970-01-01)

Quantitative proteomic analysis of the protective effect exerted by alliin on ox-LDL-injured HUVECs
by: Yuan-yuan Tang, et al.
Published: (2025-05-01)

sJAM-C as a Potential Biomarker for Coronary Artery Stenosis: Insights from a Clinical Study in Coronary Heart Disease Patients
by: Wang D, et al.
Published: (2024-12-01)

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation
by: F. T. Ageev, et al.
Published: (2011-06-01)

Treatment of Patients Chronic Coronary Heart Disease and Type 2 Diabetes Mellitus
by: E. V. Shсhukina, et al.
Published: (2023-04-01)

Heart valve calcification in patients with coronary heart disease
by: S. A. Dovgolis, et al.
Published: (2005-02-01)

Increased dietary acid load May elevate the risk of coronary artery disease severity: Findings from a cross-sectional study
by: Zeinab Ghorbani, et al.
Published: (2025-09-01)

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01)

Development and validation of a nomogram for predicting the risk of obstructive coronary artery disease in rheumatoid arthritis patients based on LDL-C, Th17 cells, and IL-17
by: Xiaoyang Wang, et al.
Published: (2024-12-01)